Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of injectable H889A for postoperative analgesia after thoracoscopic surgery under general anesthesia
CTR20243840Phase 2Completed
- Sponsor
- Huizhong Jishi Biotechnology
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H889A in postoperative pain, sponsored by Huizhong Jishi Biotechnology. Started Oct 2024; status: completed.
02
Drugs
H889A
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20243840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243840.